REL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.198800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.144800E-01
Normal-vs-Stage2
4.385800E-01
Normal-vs-Stage3
3.125200E-01
Normal-vs-Stage4
7.286000E-01
Stage1-vs-Stage2
7.654200E-01
Stage1-vs-Stage3
3.800600E-01
Stage1-vs-Stage4
1.589760E-01
Stage2-vs-Stage3
2.640400E-01
Stage2-vs-Stage4
1.010640E-01
Stage3-vs-Stage4
7.407600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.159000E-01
Normal-vs-AfricanAmerican
5.830600E-01
Normal-vs-Asian
3.218800E-01
Caucasian-vs-AfricanAmerican
1.004030E-01
Caucasian-vs-Asian
1.607410E-01
AfricanAmerican-vs-Asian
1.458850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.207600E-01
Normal-vs-Female
4.217600E-01
Male-vs-Female
9.852600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.717000E-01
Normal-vs-Age(41-60Yrs)
5.198600E-01
Normal-vs-Age(61-80Yrs)
3.898200E-01
Normal-vs-Age(81-100Yrs)
3.232000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.997400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.799000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.066400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.583980E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.590400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.455800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.942400E-01
Normal-vs-Daily Drinker
3.469400E-01
Normal-vs-Weekly Drinker
3.794600E-01
Normal-vs-Occasional Drinker
4.461000E-01
Normal-vs-Social Drinker
1.397450E-01
Non Drinker-vs-Daily Drinker
4.241200E-01
Non Drinker-vs-Weekly Drinker
8.122400E-01
Non Drinker-vs-Occasional Drinker
5.051800E-01
Non Drinker-vs-Social Drinker
5.343200E-01
Daily Drinker-vs-Weekly Drinker
6.575800E-01
Daily Drinker-vs-Occasional Drinker
1.782970E-01
Daily Drinker-vs-Social Drinker
2.262600E-01
Weekly Drinker-vs-Occasional Drinker
4.355200E-01
Weekly Drinker-vs-Social Drinker
4.822200E-01
Occasional Drinker-vs-Social Drinker
9.760800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.426600E-01
Normal-vs-Grade 2
7.405600E-02
Normal-vs-Grade 3
6.928300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.733600E-01
Grade 1-vs-Grade 3
2.254000E-01
Grade 1-vs-Grade 4
2.426600E-01
Grade 2-vs-Grade 3
4.904000E-01
Grade 2-vs-Grade 4
7.405600E-02
Grade 3-vs-Grade 4
6.928300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.401800E-01
Normal-vs-NonDiabetic
3.786400E-01
Diabetic-vs-NonDiabetic
2.001000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.810400E-01
Normal-vs-NoPancreatitis
4.033000E-01
Pancreatitis-vs-NoPancreatitis
5.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.766800E-01
Normal-vs-N1
4.472000E-01
N0-vs-N1
1.086390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.175800E-01
Normal-vs-TP53-NonMutant
3.327400E-01
TP53-Mutant-vs-TP53-NonMutant
7.730200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
